HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns.

Abstract
Infections due to Neisseria meningitidis are a major public health concern. In France, during 1999-2002, a total of 2167 clinical isolates of N. meningitidis from invasive infections were studied at the National Reference Center for Meningococci (Paris). Serogroup B strains were the most common (58%), followed by serogroup C strains (29%) and serogroup W135 strains (8%). Various phenotypes were observed, reflecting heterogeneity in the meningococcal population. Strains were susceptible to antibiotics currently used for treatment and chemoprophylaxis of meningococcal infections. However, the prevalence of meningococci with reduced susceptibility to penicillin is increasing. Such strains were heterogeneous and accounted for approximately 30% of isolates during this period, warranting continued surveillance of this phenomenon.
AuthorsAude Antignac, Magaly Ducos-Galand, Annie Guiyoule, René Pirès, Jean-Michel Alonso, Muhamed-Kheir Taha
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 37 Issue 7 Pg. 912-20 (Oct 01 2003) ISSN: 1537-6591 [Electronic] United States
PMID13130402 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Penicillin G
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Drug Resistance, Bacterial
  • France
  • Humans
  • Meningitis, Meningococcal
  • Microbial Sensitivity Tests
  • Neisseria meningitidis (drug effects, genetics)
  • Penicillin G (pharmacology)
  • Penicillin Resistance (genetics)
  • Phenotype
  • Serotyping

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: